Xultophy 100/3.6 Dosage Details: Form, Potency, Usage Instructions, and Further Information
Xultophy 100/3.6, a combination of insulin degludec and liraglutide, is a prescription medication approved by the FDA to help improve blood sugar levels in adults with type 2 diabetes. This medication comes in the form of a prefilled injection pen and is designed for subcutaneous administration once daily.
The typical starting dosage depends on whether the patient has been taking basal insulin or GLP-1 receptor agonist. For those not taking these medications, the recommended dosage is 10 units/0.36 mg, while for those who have, it is 16 units/0.58 mg. The dosage can be adjusted based on factors such as the severity of the condition, blood sugar levels, other medications, diet, and level of physical activity.
Administration involves injecting subcutaneously in the thigh, abdomen, or upper arm at the same time each day, usually following the evening meal or at bedtime. The dose can be adjusted based on fasting blood glucose levels but should not exceed the maximum approved dose of 50 dose steps (which represents the upper limit of combination units for insulin and liraglutide in one injection).
Xultophy 100/3.6 is meant to be used as a long-term treatment. If you're having trouble reading your prescription label, talk with your doctor or pharmacist. Some pharmacies offer labels with large print, Braille, or a code you scan with a smartphone to convert text to speech. You can also refer to the drug manufacturer's site to find a video showing the steps for giving a Xultophy dose.
It's important to note that if you take more Xultophy 100/3.6 than your doctor prescribes, you may develop serious side effects. If you miss a dose, take your next dose at the regular time. Don't take an extra dose or increase the next dose to make up for the missed dose.
Your doctor may also adjust your Xultophy 100/3.6 dosage if you have high or low blood sugar levels after starting treatment, or if you have liver or kidney problems or other medical conditions. If you take certain other medications or stop using them, your doctor may also need to adjust your Xultophy 100/3.6 dosage.
In summary:
- Dosage range: Usually starting at 16 dose steps once daily, titrated up to a maximum of 50 dose steps daily.
- Frequency: Once daily.
- Administration route: Subcutaneous injection in thigh, abdomen, or upper arm.
This approach aims to improve glycemic control while minimizing side effects by combining insulin degludec's basal insulin action with liraglutide's GLP-1 receptor agonist effects. It's crucial to follow your doctor's instructions and report any unusual symptoms or concerns.
- When deciding on the dosage for Xultophy 100/3.6, it's important to consider if the patient is already on basal insulin or a GLP-1 receptor agonist, with a starting dosage of 10 units/0.36 mg for non-users, and 16 units/0.58 mg for current users.
- The recommended frequency for Xultophy 100/3.6 is a once daily subcutaneous injection, usually administered following the evening meal or at bedtime, in the thigh, abdomen, or upper arm.
- The use of Xultophy 100/3.6 is intended as a long-term treatment for managing health-and-wellness, specifically blood sugar levels in adults with type 2 diabetes, and it works by combining insulin degludec's basal insulin action with liraglutide's GLP-1 receptor agonist effects to improve glycemic control while minimizing side effects.
